Trial Profile
The Value of Orencia in Rapidly Progressing Rheumatoid Arthritis: A Chart Review Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Jul 2022
Price :
$35
*
At a glance
- Drugs Abatacept (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Bristol-Myers Squibb
- 01 Jul 2022 Status changed from active, no longer recruiting to completed.
- 17 Apr 2020 Planned End Date changed from 30 Jan 2019 to 14 May 2020.
- 17 Apr 2020 Planned primary completion date changed from 30 Jan 2019 to 14 May 2020.